BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12504956)

  • 21. Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects.
    Wex J; Abou-Setta AM; Clerici G; Di Renzo GC
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):128-35. PubMed ID: 21620558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
    Kim A; Shim JY
    BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An update on the controversies of tocolytic therapy for the prevention of preterm birth.
    Ingemarsson I; Lamont RF
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):1-9. PubMed ID: 12580832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of oxytocin and atosiban on the modulation of heart rate in pregnant women.
    Weissman A; Tobia RS; Burke YZ; Maxymovski O; Drugan A
    J Matern Fetal Neonatal Med; 2017 Feb; 30(3):329-333. PubMed ID: 27030149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An oxytocin inhibitor for suppressing preterm labour.
    Crankshaw DJ
    Br J Obstet Gynaecol; 1988 Dec; 95(12):1339-41. PubMed ID: 3224097
    [No Abstract]   [Full Text] [Related]  

  • 26. [Atosiban treatment for preterm labor--financial considerations and savings by implementing clinical guidelines].
    Hadar E; Mansur N; Ambar I; Hod M
    Harefuah; 2011 Jun; 150(6):502-6, 553. PubMed ID: 21800486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.
    Goodwin TM; Paul R; Silver H; Spellacy W; Parsons M; Chez R; Hayashi R; Valenzuela G; Creasy GW; Merriman R
    Am J Obstet Gynecol; 1994 Feb; 170(2):474-8. PubMed ID: 8116700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tocolysis in preterm labour--current recommendations].
    Wielgoś M; Bomba-Opoń DA
    Ginekol Pol; 2014 May; 85(5):332-4. PubMed ID: 25011212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour.
    Siassakos D; O'Brien K; Draycott T
    J Obstet Gynaecol; 2009 Aug; 29(6):507-11. PubMed ID: 19697198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Fallon A; Fallon UB
    BJOG; 2007 Aug; 114(8):1043; author reply 1043-4. PubMed ID: 17635490
    [No Abstract]   [Full Text] [Related]  

  • 31. Atosiban versus usual care for the management of preterm labor.
    Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
    J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxytocin antagonists: clinical and scientific considerations.
    Thornton S; Vatish M; Slater D
    Exp Physiol; 2001 Mar; 86(2):297-302. PubMed ID: 11429647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and clinical experience with the new evidence-based tocolytic atosiban.
    Husslein P
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):633-41. PubMed ID: 12190838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban.
    Bossmar T
    J Perinat Med; 1998; 26(6):458-65. PubMed ID: 10224602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development and introduction of anti-oxytocic tocolytics.
    Lamont RF
    BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse and beneficial effects of tocolytic therapy.
    Pryde PG; Besinger RE; Gianopoulos JG; Mittendorf R
    Semin Perinatol; 2001 Oct; 25(5):316-40. PubMed ID: 11707019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.
    Moutquin JM; Sherman D; Cohen H; Mohide PT; Hochner-Celnikier D; Fejgin M; Liston RM; Dansereau J; Mazor M; Shalev E; Boucher M; Glezerman M; Zimmer EZ; Rabinovici J
    Am J Obstet Gynecol; 2000 May; 182(5):1191-9. PubMed ID: 10819857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atosiban and nifedipine in the suppression of pre-term labour: a comparative study.
    Saleh SS; Al-Ramahi MQ; Al Kazaleh FA
    J Obstet Gynaecol; 2013 Jan; 33(1):43-5. PubMed ID: 23259877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-Term Outcomes of Atosiban in the Treatment of Preterm Labour at the Sultan Qaboos University Hospital, Muscat, Oman: A tertiary care experience.
    Al-Riyami N; Al-Badri H; Jaju S; Pillai S
    Sultan Qaboos Univ Med J; 2021 May; 21(2):e260-e265. PubMed ID: 34221474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.